H.U. Group Holdings, Inc. (MRCHF)
OTCMKTS · Delayed Price · Currency is USD
25.99
0.00 (0.00%)
At close: Sep 25, 2025
H.U. Group Holdings Revenue
H.U. Group Holdings had revenue of 61.40B JPY in the quarter ending June 30, 2025, with 3.24% growth. This brings the company's revenue in the last twelve months to 244.95B, up 2.15% year-over-year. In the fiscal year ending March 31, 2025, H.U. Group Holdings had annual revenue of 243.03B with 2.56% growth.
Revenue (ttm)
244.95B JPY
Revenue Growth
+2.15%
P/S Ratio
0.79
Revenue / Employee
45.00M JPY
Employees
5,444
Market Cap
1.34B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 243.03B | 6.08B | 2.56% |
Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
Mar 31, 2021 | 223.02B | 34.30B | 18.18% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |